HANNAH BREAU: Open Payments
NPI 1699445510 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,060 in 114 payments from 17 companies in 2025. Trend: 2023 $2,888 · 2024 $2,337 · 2025 $2,060
Food & beverage: $2,060
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 19 | $389 |
| UCB, Inc. | 23 | $360 |
| Janssen Biotech, Inc. | 19 | $318 |
| ABBVIE INC. | 11 | $160 |
| Galderma Laboratories, L.P. | 7 | $154 |
| Novartis Pharmaceuticals Corporation | 9 | $148 |
| LEO Pharma Inc. | 6 | $111 |
| GENZYME CORPORATION | 4 | $93 |
| Incyte Corporation | 3 | $84 |
| PFIZER INC. | 3 | $57 |
Products named: Bimzelx, TREMFYA, TALTZ, NEMLUVIO, SKYRIZI, EBGLYSS, COSENTYX, DUPIXENT.
Industry payments across AR — which companies pay providers there.
